- Home
- USB vs MDT Comparison
USB vs MDT Comparison
Compare USB & MDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | USB | MDT |
|---|---|---|
| Founded | 1863 | 1949 |
| Country | United States | Ireland |
| Employees | 68520 | N/A |
| Industry | Major Banks | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 98.4B | 107.0B |
| IPO Year | N/A | 2014 |
Fundamental Metrics
Financial Performance| Metric | USB | MDT |
|---|---|---|
| Price | $63.34 | $86.21 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 19 | 21 |
| Target Price | $60.28 | ★ $108.21 |
| AVG Volume (30 Days) | ★ 7.9M | 6.9M |
| Earning Date | 04-16-2026 | 06-03-2026 |
| Dividend Yield | ★ 3.70% | 3.58% |
| EPS Growth | N/A | ★ 3.32 |
| EPS | N/A | ★ 3.73 |
| Revenue | N/A | ★ $36,364,000,000.00 |
| Revenue This Year | $16.09 | $8.91 |
| Revenue Next Year | $5.36 | $6.54 |
| P/E Ratio | ★ $12.72 | $22.89 |
| Revenue Growth | N/A | ★ 8.43 |
| 52 Week Low | $43.83 | $73.31 |
| 52 Week High | $64.84 | $106.33 |
Technical Indicators
Market Signals| Indicator | USB | MDT |
|---|---|---|
| Relative Strength Index (RSI) | 56.68 | 60.45 |
| Support Level | $52.92 | $85.35 |
| Resistance Level | $63.39 | $89.01 |
| Average True Range (ATR) | 1.16 | 2.03 |
| MACD | -0.27 | 0.27 |
| Stochastic Oscillator | 44.30 | 70.79 |
Price Performance
Historical ComparisonAbout USB U.S. Bancorp
With assets of around $700 billion, U.S. Bancorp is one of the largest regional banks in the US with its footprint in 26 states. The bank's branch network is mostly in Midwestern and Western markets. U.S. Bancorp has a comprehensive product set, with offerings in retail and commercial banking, credit cards, mortgages, payment services, trust, wealth, and capital market services.
About MDT Medtronic plc.
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.